EUVIMEDEUVIMED entdecken
Leserbrief

Correspondence on reply to “Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD”

Shi-Jie Zhang, Guiying Gao

Clinical and Molecular Hepatology · 06.11.2026

DOI: 10.3350/cmh.2026.0511 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Shi-Jie Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This correspondence is in response to [Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD"]

Autor:innen und Institutionen

  • Children's Medical Center, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • The Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guizhou, China. gaoguiying@gmc.edu.cn.

Zitieren

APA

Zhang, S. J., & Gao, G. (2026). Correspondence on reply to “Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0511

Vancouver

Zhang SJ, Gao G. Correspondence on reply to “Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0511

BibTeX
@article{Zhang2026,
  author = {Zhang, Shi-Jie and Gao, Guiying},
  title = {Correspondence on reply to “Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0511}
}
Kostenlos starten →